Successful desensitization in a boy with severe cow’s milk allergy by a combination therapy using omalizumab and rush oral immunotherapy

BACKGROUND: Rush oral immunotherapy (OIT) combined with omalizumab (OMB) has been reported to be an effective and safe treatment for severe milk allergies. However, no report has described long-term follow-up observations after OMB discontinuation. The purpose of this case report was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Masaya, Taniuchi, Shoichiro, Soejima, Kazuhiko, Hatano, Yasuko, Yamanouchi, Sohsaku, Kaneko, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461908/
https://www.ncbi.nlm.nih.gov/pubmed/26064142
http://dx.doi.org/10.1186/s13223-015-0084-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461908/
https://www.ncbi.nlm.nih.gov/pubmed/26064142
http://dx.doi.org/10.1186/s13223-015-0084-y

Ejemplares similares